Cosmo Bio Company,Limited (TYO:3386)
1,225.00
+6.00 (0.49%)
Jun 4, 2026, 3:30 PM JST
Cosmo Bio Company,Limited Market Cap
Cosmo Bio Company,Limited has a market cap or net worth of 6.95 billion as of June 4, 2026. Its market cap has increased by 5.20% in one year.
Market Cap
6.95B
Enterprise Value
4.32B
Revenue
11.00B
Ranking
n/a
PE Ratio
20.04
Stock Price
1,225.00
Market Cap Chart
Since September 27, 2005, Cosmo Bio Company,Limited's market cap has decreased from 11.66B to 6.95B, a decrease of -40.41%. That is a compound annual growth rate of -2.47%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 3, 2026 | 6.92B | -6.56% |
| Dec 30, 2025 | 7.40B | 18.67% |
| Dec 30, 2024 | 6.24B | 8.71% |
| Dec 29, 2023 | 5.74B | -2.42% |
| Dec 30, 2022 | 5.88B | -12.66% |
| Dec 30, 2021 | 6.73B | -7.40% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Chugai Pharmaceutical | 12.54T |
| HOYA Corporation | 8.81T |
| Takeda Pharmaceutical Company | 7.66T |
| Otsuka Holdings | 5.96T |
| ADR120S | 7.08B |
| HYUGA PRIMARY CARE | 7.05B |
| Precision System Science | 6.87B |
| StemCell Institute | 6.83B |